Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary B Whitlatch

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Transplantation|July 15, 2025
Evaluating Hyperparathyroidism in Simultaneous Pancreas-Kidney Transplant Recipients: A Single-Center ExperienceLane T Cavey, Lindsay A Kohan, Ruchin Patel, et al.
Clinical and Translational Science|May 3, 2024
Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance testAmber L Beitelshees, Elizabeth A Streeten, Zhinous Shahidzadeh Yazdi, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance testAmber L Beitelshees, Elizabeth A Streeten, Zhinous Shahidzadeh Yazdi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarkerSimeon I Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, et al.
Diabetes, Obesity & Metabolism|August 23, 2023
Pharmacogenetics of sodium-glucose co-transporter-2 inhibitors: Validation of a sex-agnostic pharmacodynamic biomarkerSimeon I Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, et al.
Clinical and Translational Science|November 22, 2024
Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamicsJoshua P Lewis, Kathleen A Ryan, Elizabeth A Streeten, et al.
Clinical and Translational Science|May 17, 2026
Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic ResponsesMay E Montasser, Salma A Bargal, Elizabeth A Streeten, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectivenessSimeon I Taylor, May E Montasser, Ashley H Yuen, et al.
Diabetes, Obesity & Metabolism|June 1, 2023
Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectivenessSimeon I Taylor, May E Montasser, Ashley H Yuen, et al.
Journal of Toxicology and Environmental Health. Part A|November 27, 2024
Thirty years of surveillance of depleted uranium-exposed Gulf War veterans demonstrate continued effects to bone healthMelissa A McDiarmid, Sammy Almashat, Marianne Cloeren, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Transplantation|July 15, 2025
Evaluating Hyperparathyroidism in Simultaneous Pancreas-Kidney Transplant Recipients: A Single-Center ExperienceLane T Cavey, Lindsay A Kohan, Ruchin Patel, et al.
Clinical and Translational Science|May 3, 2024
Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance testAmber L Beitelshees, Elizabeth A Streeten, Zhinous Shahidzadeh Yazdi, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance testAmber L Beitelshees, Elizabeth A Streeten, Zhinous Shahidzadeh Yazdi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarkerSimeon I Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, et al.
Diabetes, Obesity & Metabolism|August 23, 2023
Pharmacogenetics of sodium-glucose co-transporter-2 inhibitors: Validation of a sex-agnostic pharmacodynamic biomarkerSimeon I Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, et al.
Clinical and Translational Science|November 22, 2024
Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamicsJoshua P Lewis, Kathleen A Ryan, Elizabeth A Streeten, et al.
Clinical and Translational Science|May 17, 2026
Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic ResponsesMay E Montasser, Salma A Bargal, Elizabeth A Streeten, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectivenessSimeon I Taylor, May E Montasser, Ashley H Yuen, et al.
Diabetes, Obesity & Metabolism|June 1, 2023
Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectivenessSimeon I Taylor, May E Montasser, Ashley H Yuen, et al.
Journal of Toxicology and Environmental Health. Part A|November 27, 2024
Thirty years of surveillance of depleted uranium-exposed Gulf War veterans demonstrate continued effects to bone healthMelissa A McDiarmid, Sammy Almashat, Marianne Cloeren, et al.
Pageof 3